TARSUS PHARMACEUTICALS INC (TARS) Earnings History & Surprises
NASDAQ:TARS • US87650L1035
72.87 USD
-0.39 (-0.53%)
Last: Mar 9, 2026, 01:35 PM
Past quarterly earnings results for TARSUS PHARMACEUTICALS INC (TARS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate$0.02
Revenue Estimate153.64M
Last Reported
Release DateFeb 23, 2026
PeriodQ4 / 2025
EPS Reported-$0.20
EPS Surprise -106.09%
Revenue Surprise 2.85%
Beat Rate
88%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.20 | -0.10 | -106.09% | 66.67% | 151.668M | 147.46M | 2.85% | 128.39% |
| Q3 2025 | -0.30 | -0.36 | 16.07% | 50.82% | 118.697M | 117.53M | 0.99% | 146.68% |
| Q2 2025 | -0.48 | -0.41 | -17.77% | 45.45% | 102.66M | 97.596M | 5.19% | 151.54% |
| Q1 2025 | -0.64 | -0.75 | 14.11% | 36.63% | 78.335M | 73.917M | 5.98% | 183.68% |
| Q4 2024 | -0.60 | -0.76 | 20.78% | 54.20% | 66.408M | 59.494M | 11.62% | 407.86% |
| Q3 2024 | -0.61 | -0.99 | 38.50% | 52.34% | 48.118M | 44.306M | 8.60% | 2,471.78% |
| Q2 2024 | -0.88 | -0.94 | 6.62% | 24.79% | 40.813M | 32.297M | 26.37% | - |
| Q1 2024 | -1.01 | -1.23 | 17.81% | -14.77% | 27.614M | 17.805M | 55.09% | 1,004.56% |
| Q4 2023 | -1.31 | -1.39 | 5.75% | -167.35% | 13.076M | 5.778M | 126.31% | 30.76% |
| Q3 2023 | -1.28 | -1.39 | 8.10% | -52.38% | 1.871M | 407.796K | 358.81% | - |
| Q2 2023 | -1.17 | -1.10 | -6.36% | -387.50% | 1.795M | -100.00% | -100.00% | |
| Q1 2023 | -0.88 | -0.96 | 8.70% | 10.20% | 2.5M | 3.188M | -21.58% | 362.96% |
| Q4 2022 | -0.49 | -0.70 | 30.38% | 31.94% | 10M | 10.2M | -1.96% | 2,841.18% |
| Q3 2022 | -0.84 | -0.99 | 15.35% | -10.53% | 2.975M | -100.00% | -100.00% | |
| Q2 2022 | -0.24 | -0.60 | 60.15% | -172.73% | 15.28M | 13.26M | 15.23% | -30.61% |
| Q1 2022 | -0.98 | -0.94 | -4.68% | -308.51% | 540K | 2.244M | -75.94% | -98.38% |
| Q4 2021 | -0.72 | -0.74 | 2.98% | -5.88% | 340K | 6.204M | -94.52% | - |
| Q3 2021 | -0.76 | -0.44 | -71.68% | 79.51% | 1.24M | 5.44M | -77.21% | - |
| Q2 2021 | 0.33 | -0.49 | 167.87% | - | 22.02M | 4.624M | 376.21% | - |
| Q1 2021 | 0.47 | -0.65 | 172.00% | - | 33.43M | - | - | |
| Q4 2020 | -0.68 | -0.67 | -1.01% | - | - | - | ||
| Q3 2020 | -3.71 | -0.54 | -586.27% | - | - | - | ||
| Q2 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-23.42%
Max EPS beat (4)
16.07%
Min EPS beat (4)
-106.10%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
3.75%
Max Revenue beat (4)
5.98%
Min Revenue beat (4)
0.99%
Analysis
In the last 4 quarters, TARS has beaten EPS estimates in 2 out of 4 releases
TARS has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, TARS reported -23.4% below the EPS estimates on average.
In the last 4 quarters, TARS has beaten the revenue estimates by 3.8% on average.
TARSUS PHARMACEUTICALS INC / TARS Earnings FAQ
Can you provide the last earnings date for TARSUS PHARMACEUTICALS INC?
TARSUS PHARMACEUTICALS INC (TARS) last reported earnings on 2/23/2026.
Did TARS stock beat earnings estimates in the most recent quarter?
TARSUS PHARMACEUTICALS INC (TARS) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often TARSUS PHARMACEUTICALS INC beats earnings estimates?
In the last 4 quarters, TARSUS PHARMACEUTICALS INC (TARS) has beaten EPS estimates in 2 out of 4 releases.